Gilead Sciences Acquires Tubulis in 315 Billion Deal to Strengthen Oncology Pipeline TJX Companies Tops List of Dividend Growth Stocks as Analysts Lift Price Targets Novartis Lifts Annual Sales and Profit Forecast Amid Strong Operational Momentum US GDP Rose at 2 Annual Rate in First Quarter Signaling Rebound WTI Crude Oil Forecast Market Watchers Eye Asymmetric Price Swings on IranRelated Headlines eHealth EHTH Receives Price Target Increase Amid Operational Improvements Westport Fuel Systems WPRT Q1 2026 Earnings EPS Exceeds Expectations Amid Revenue Uncertainty Stock Declines PXED Q1 2026 Earnings Strong EPS Beat Drives Stock Higher OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance VTGN Q1 2026 Earnings Narrowing Losses as Pipeline Progress Steadies Investor Sentiment CSGP Q1 2026 Earnings EPS Surges 225 Above Expectations Amidst Modest Stock Decline Shift4 Payments Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Rectitude Holdings RECT Tests Key Support After 366 Decline Interactive Brokers Group IBKR Faces Headwinds Stock Slides 296 Amid Sector Rotation Blueport Acquisition Ltd BPAC Holds Steady Near Key Resistance Level Iamgold IAG Slides 292 Support at 1596 Faces Critical Test FTAI Aviation Ltd FTAI Surges 23 as Aerospace Momentum Builds Tests Key Resistance Zone AI Economy Reshapes Labor Market BlueCollar Workers May Gain as WhiteCollar Entry Jobs Slow Evolution Petroleum EPM Q1 2026 Earnings Steep Earnings Miss Sends Stock Lower Sally Beauty Holdings SBH Inches Higher as Stock Consolidates Near Key Levels Nexentis Technologies NXTS Gains 136 as Stock Tests Key Resistance Near 470 Locafy Limited LCFY Retreats 294 as Shares Test Key Technical Levels Murano Global Investments Warrants MRNOW Plunge Amid Thin Trading Key Levels to Watch Innovex International INVX Slips 25 as Selling Pressure Builds Near Resistance SciSparc Ltd SPRC Gains 207 in Light Trading Key Support Holds Above 400 Akamai Technologies AKAM Edges Higher as Bulls Test Resistance Near 157 Agios Pharmaceuticals AGIO Slips 11 as Stock Hovers Near Key Support